Who owns TELOMIR PHARMACEUTICALS INC?
- Ticker: TELO
- CUSIP Number: 87975f104
Tip: Access positions for across all investors
Analyze quarterly positions in Telomir Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Telomir Pharmaceuticals stock
Who bought or sold TELOMIR PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 1.1M | $1.5M | 3% | Dec 2025 |
|
| BlackRock | 291k | $405k | -21% | Sep 2025 |
|
| Geode Capital Management | 224k | $298k | 14% | Dec 2025 |
|
| Millennium Management | 222k | $309k | -10% | Sep 2025 |
|
| Raymond James Financial | 75k | $105k | 4102% | Sep 2025 |
|
| State Street Corporation | 59k | $78k | 0% | Dec 2025 |
|
| Bank of New York Mellon | 52k | $68k | 0% | Dec 2025 |
|
| Suncoast Equity Management | 51k | $68k | 0% | Dec 2025 |
|
| Northern Trust | 42k | $56k | 0% | Dec 2025 |
|
| Pensionmark Financial Group | 35k | $47k | 100% | Dec 2025 |
|
| Advisor Group Holdings | 25k | $33k | 17% | Sep 2025 |
|
| Resources Investment Advisors | 23k | $31k | 0% | Dec 2025 |
|
| Virtu Financial | 14k | $19k | 100% | Dec 2025 |
|
| UBS Group | 14k | $19k | -78% | Dec 2025 |
|
| Vestmark Advisory Solutions | 13k | $17k | 100% | Dec 2025 |
|
| Hartland & Co | 13k | $17k | 0% | Dec 2025 |
|
| Jane Street | 12k | $16k | -41% | Dec 2025 |
|
| Mariner Wealth Advisors | 12k | $16k | -42% | Dec 2025 |
|
| Kestra Private Wealth Services | 11k | $15k | 0% | Dec 2025 |
|
| Regions Bank | 11k | $14k | 0% | Dec 2025 |
|
| Two Sigma Securities | 10k | $13k | 100% | Dec 2025 |
|
| Praetorian Wealth Management | 10k | $13k | -50% | Dec 2025 |
|
| IFP Advisors | 3.0k | $4.0k | 100% | Dec 2025 |
|
| Fortitude Family Office | 1.3k | $1.8k | 100% | Dec 2025 |
|
| Jones Financial Companies, L.L | 600.00 | $834.000000 | 0% | Sep 2025 |
|
| Royal Bank of Canada | 599.00 | $0 | -37% | Sep 2025 |
|
| EverSource Wealth Advisors | 379.00 | $503.994200 | 0% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 206.00 | $274.000600 | -41% | Dec 2025 |
|
| SBI Securities | 4.00 | $6.000000 | 0% | Sep 2025 |
|
| Barclays | 2.00 | $3.000000 | 0% | Dec 2025 |
|
Who sold out of Telomir Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Y-Intercept | Jun 2025 | 64k | $81k |
| AQR Capital Management | Jun 2025 | 33k | $42k |
| Goldman Sachs Group | Sep 2025 | 23k | $32k |
| Jain Global | Jun 2025 | 16k | $21k |
| Qube Research & Technologies | Sep 2025 | 11k | $15k |
| FMR | Jun 2025 | 5.6k | $7.0k |
| Tower Research Capital | Sep 2025 | 1.3k | $1.7k |
| SRS Capital Advisors | Sep 2025 | 9.00 | $11.999700 |
| CWM | Sep 2025 | 2.00 | $0 |